BridgeMD
New treatment option for Functional Neurological Disorder
Official title Pilot Neurobehavioral Therapy for Functional Neurological Disorder
ClinicalTrials.gov ID: NCT06873698
What this study is testing
- What it's testing
- The goal of this pilot randomized clinical trial is to learn if Neurobehavioral Therapy (NBT) works to treat motor functional neurological disorder (mFND) (also referred to as functional motor disorder). The main questions it aims to answer are: Does NBT lower mFND symptoms?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- Individuals diagnosed with Motor Functional Neurological Disorder (mFND)
- Individuals aged 18-100 years
- At least 1 mFND symptom during the year prior to enrollment
You likely can't join if
- Current or past year self-injurious behavior
- Current suicidality (PHQ-9 question 9 rated as 1 or above)
- Current or past year psychosis
- Pending litigation or current application for long term disability
- Active substance or alcohol use disorders (dependence), at the discretion of the investigator if they preclude participation in the study
- Serious illness requiring systemic treatment or hospitalization; the participant either completes therapy or is clinically stable on therapy, for at...
See the full eligibility criteria
- Individuals diagnosed with Motor Functional Neurological Disorder (mFND)
- Individuals aged 18-100 years
- At least 1 mFND symptom during the year prior to enrollment
- Current or past year self-injurious behavior
- Current suicidality (PHQ-9 question 9 rated as 1 or above)
- Current or past year psychosis
- Pending litigation or current application for long term disability
- Active substance or alcohol use disorders (dependence), at the discretion of the investigator if they preclude participation in the study
- Serious illness requiring systemic treatment or hospitalization; the participant either completes therapy or is clinically stable on therapy, for at least 30 days prior to study entry
- Inability to fill out the self-report surveys
- Inability or unwillingness to participate in NBT and assigned homework
- Currently enrolled in NBT aimed at mFND
The study team makes the final eligibility decision.
Where it's taking place
- Providence, Rhode Island, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Providence, Rhode Island, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.